Paul Jaminet is the founder of Angiex. Angiex has raised $68M in total funding. Backed by Peter Thiel. Based in Cambridge, MA.
Paul Jaminet is the Co-Founder and Chief Executive Officer of Angiex, a biopharmaceutical company developing novel therapies for solid cancers using next-generation antibody-drug conjugates (ND-ADCs). Angiex's lead ND-ADC, AGX101, is currently dosing in Phase 1 clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library